Peter Rahmer, See remarks at Relay Therapeutics, Inc. (RLAY), sold 247 shares at $2.84 ($701) on 2025-03-27, disclosed to the SEC on 2025-03-31.
Open-market sale of $701 RLAY by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RLAY | SELL | 2026-07-02 | $955K | — | Filing → |
| RLAY | SELL | 2026-04-30 | $11K | — | Filing → |
| RLAY | SELL | 2026-01-29 | $100K | — | Filing → |